P, T., JN, T., J, B., & Jr, E. C. (1996). Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatric nephrology (Berlin, Germany), 10(5), 590. https://doi.org/10.1007/s004670050167
Chicago Style (17th ed.) CitationP, Tarshish, Tobin JN, Bernstein J, and Edelmann CM Jr. "Cyclophosphamide Does Not Benefit Patients with Focal Segmental Glomerulosclerosis. A Report of the International Study of Kidney Disease in Children." Pediatric Nephrology (Berlin, Germany) 10, no. 5 (1996): 590. https://doi.org/10.1007/s004670050167.
MLA (9th ed.) CitationP, Tarshish, et al. "Cyclophosphamide Does Not Benefit Patients with Focal Segmental Glomerulosclerosis. A Report of the International Study of Kidney Disease in Children." Pediatric Nephrology (Berlin, Germany), vol. 10, no. 5, 1996, p. 590, https://doi.org/10.1007/s004670050167.